entity

metabolic_reprogramming

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about metabolic_reprogramming: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

5Connections
22Hypotheses
3Analyses
3Outgoing
2Incoming
3Experiments
3Debates

No AI portrait yet

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

Microglial Metabolic Reprogramming

mechanism · 1360 words

Outgoing (3)

TargetRelationTypeStr
CELLULAR_SENESCENCEdeterminesphenotype0.64
oxidative_stressregulatesphenotype0.56
MYOCARDIAL_FIBROSIScontributes_tophenotype0.56

Incoming (2)

SourceRelationTypeStr
TMEactivatesphenotype0.64
HIF1Aregulatesgene0.60

Targeting Hypotheses (22)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Metabolic Reprogramming to Reverse Senescence 1.000 - Senescent cell clearance as neurodegener
TREM2-mTOR Co-Agonism for Metabolic Reprogramming 0.803 neurodegeneration TREM2 agonism vs antagonism in DAM micro
TREM2-CSF1R Cross-Talk in Microglial Metabolic Reprogramming 0.748 neurodegeneration Gene expression changes in aging mouse b
Metabolic Reprogramming via Microglial Glycolysis Inhibition 0.672 neurodegeneration Synaptic pruning by microglia in early A
Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem 0.646 neurodegeneration Selective vulnerability of entorhinal co
Cell-Type Specific Metabolic Reprogramming 0.643 neurodegeneration Cell type vulnerability in Alzheimers Di
SASP-Driven Microglial Metabolic Reprogramming in Synaptic P 0.643 neurodegeneration Senolytic therapy for age-related neurod
Astrocyte Metabolic Reprogramming via APOE4 Correction 0.636 neurodegeneration Cell type vulnerability in Alzheimer's D
Disease-Associated Microglia Metabolic Reprogramming 0.631 neurodegeneration Cell type vulnerability in Alzheimers Di
NRF2-Mediated Metabolic Reprogramming: HBOT as Direct NAMPT/ 0.602 neurodegeneration View
Metabolic Reprogramming via Coordinated Multi-Gene CRISPR Ci 0.599 neurodegeneration CRISPR-based therapeutic approaches for
APOE4 drives astrocyte metabolic reprogramming toward glycol 0.580 neuroscience APOE4-driven lipid metabolism dysregulat
Digital Twin-Guided Metabolic Reprogramming 0.550 neurodegeneration Digital biomarkers and AI-driven early d
TREM2-Mediated Microglial Metabolic Reprogramming Accelerate 0.494 neuroscience Circuit-level neural dynamics in neurode
Oligodendrocyte Progenitor Cell Metabolic Reprogramming 0.486 neurodegeneration Which cell types show the most significa
Metabolic Reprogramming Toward GAPDH Inhibition 0.450 neurodegeneration How does controlled lysosomal membrane p
Mitochondrial Pyruvate Carrier Inhibition to Force Metabolic 0.347 metabolomics Metabolomic signatures of neurodegenerat
NAD+-SIRT1-H3K9me3 restoration enables true senescence rever 0.000 Alzheimer's disease Can metabolic interventions truly revers
CCR2-Mediated Microglial Replacement Drives mTOR-HIF1α Metab 0.000 developmental neurobiology Do perinatal immune challenges create pe
TBK1 Deficiency Disrupts Microglial Metabolic Reprogramming, 0.000 ALS What are the mechanisms by which microgl
CCR2-Mediated Microglial Replacement Drives mTOR-HIF1α Metab 0.000 developmental neurobiology Do perinatal immune challenges create pe
Microglial Phenotypic Polarization via CSF1R-Mediated Metabo 0.000 developmental neurobiology Do perinatal immune challenges create pe

Mentioning Analyses (3)

Scientific analyses that reference this entity

Can metabolic interventions truly reverse established cellular senescence or onl

cell biology | 2026-04-08 | 1 hypotheses

How do astrocyte-neuron metabolic interactions change during disease progression

neurodegeneration | 2026-04-04 | 3 hypotheses Top: 0.541

Metabolic reprogramming in neurodegenerative disease

neurodegeneration | 2026-04-02 | 3 hypotheses Top: 0.652

Experiments (3)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
Clinical outcome analysis based on IDH mutation status clinical gliomas 0.850 0.00 human patients proposed N/A
Proposed experiment from debate on Astrocytes adopt A1 (neurotoxic) an falsification Neurodegeneration 0.400 0.50 cell_line completed $100,000
Proposed experiment from debate on Microglia activate astrocytes via I falsification Neuroinflammation 0.400 0.50 cell_line completed $80,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Saturation mutagenesis of twenty disease-associated regulatory elements at singl [PMID:31395865] ["Kircher M", "Xiong C", "Martin B", "Sc Nature Communications 2019 267
Bergenin attenuates traumatic brain injury via inhibition of microglial PFKFB3-d [PMID:41520557] Sun B, Zhang A, Feng S, Jamali AW, Jia Z Int Immunopharmacol 2026 1
HK1 and HK2 Beyond Glycolysis: Mitochondrial Interactions and Dual Roles in Meta [PMID:41387352] Pesce NA, Seminara G, Giarrusso G, Tomas Adv Biol (Weinh) 2026 1
Glucose Metabolic Reprogramming in Microglia: Implications for Neurodegenerative [PMID:39987285] Fang M, Zhou Y, He K, Lu Y, Tao F, Huang Mol Neurobiol 2025 1
Deficiency of Microglial Hv1 Protects Against Lipopolysaccharide-Induced Neuroin [PMID:40911376] Sun L, Wang X, Guan S, Zhang P, Chen D, FASEB J 2025 1
The PI3K/Akt Pathway and Glucose Metabolism: A Dangerous Liaison in Cancer. [PMID:38904014] Fontana F, Giannitti G, Marchesi S, Limo Int J Biol Sci 2024 1
AST-120 alleviates renal ischemia-reperfusion injury by inhibiting HK2-mediated [PMID:39217289] Zhou J, Zhang J, Xu F, Gao H, Wang L, Zh Mol Med 2024 1
Hexokinase 2-mediated gene expression via histone lactylation is required for he [PMID:37463576] Rho H, Terry AR, Chronis C, Hay N Cell Metab 2023 1
IDH2 stabilizes HIF-1α-induced metabolic reprogramming and promotes chemoresista [PMID:36637036] Shigeta K, Hasegawa M, Hishiki T, Naito EMBO J 2023 1
NAD(+) metabolism, stemness, the immune response, and cancer. [PMID:33384409] Navas LE, Carnero A Signal Transduct Target Ther 2021 1
Cancer-associated mutation and beyond: The emerging biology of isocitrate dehydr [PMID:31131326] Tommasini-Ghelfi S, Murnan K, Kouri FM, Sci Adv 2019 1
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcino [PMID:28622513] Cancer Genome Atlas Research Network. El Cell 2017 1
Diagnostic, prognostic and predictive relevance of molecular markers in gliomas. [PMID:25944653] Brandner S, von Deimling A Neuropathol Appl Neurobiol 2015 1
IDH1 and IDH2 mutations in gliomas. [PMID:19228619] Yan H, Parsons DW, Jin G, McLendon R, Ra N Engl J Med 2009 1
Modulating LRP1 Pathways in Alzheimer's Disease: Mechanistic Insights and Emergi [PMID:41772271] Mushtaq T, Hameed H, Khan MA, Tariq U, H Molecular neurobiology 2026 0
Crosstalk Between [PMID:41899603] ["Ren Y", "Tang D", "Ding X", "He M"] Cancers 2026 0
Resibufogenin protects against atherosclerosis in ApoE(-/-) mice through blockin [PMID:40258472] Xiaoyang C, Yijun C, Chenguang Z, Wanyin J Adv Res 2026 0
High- and Low-Fat Dairy Consumption and Long-Term Risk of Dementia: Evidence Fro [PMID:41406402] Du Y, Borné Y, Samuelsson J, Glans I, Hu Neurology 2026 0
Macrophage-Specific E3 Ubiquitin Ligase TRIM31 Reduces Atherosclerotic Plaque Fo [PMID:41410044] Zhang J, Yu L, Yang W, Cao L, Wang X et Circulation 2026 0
The role of astrocytes in Alzheimer's disease: Pathophysiology, biomarkers, and [PMID:41527736] Abedin MJ, Kastanenka KV J Alzheimers Dis 2026 0

Debates (3)

Multi-agent debates referencing this entity

The highest-ranked hypothesis assumes senescence reversibility through metabolic

closed · Rounds: 4 · Score: 0.95 · 2026-04-09

How do astrocyte-neuron metabolic interactions change during disease progression

closed · Rounds: 4 · Score: 0.93 · 2026-04-04

How does metabolic reprogramming (glucose metabolism shifts, brain insulin resis

closed · Rounds: 4 · Score: 0.73 · 2026-04-02

Related Research

Hypotheses and analyses mentioning metabolic_reprogramming in their description or question text

Cell-Type Specific Metabolic Reprogramming

Score: 0.643 · neurodegeneration · 2026-04-13

## Mechanistic Overview Cell-Type Specific Metabolic Reprogramming starts from the claim that modulating PPARA within th

SASP-Driven Microglial Metabolic Reprogramming in Synaptic Phagocytosis

Score: 0.643 · neurodegeneration · 2026-04-07

## Mechanistic Overview SASP-Driven Microglial Metabolic Reprogramming in Synaptic Phagocytosis starts from the claim th

Astrocyte Metabolic Reprogramming via APOE4 Correction

Score: 0.636 · neurodegeneration · 2026-04-04

## Mechanistic Overview Astrocyte Metabolic Reprogramming via APOE4 Correction starts from the claim that modulating APO

Disease-Associated Microglia Metabolic Reprogramming

Score: 0.631 · neurodegeneration · 2026-04-12

## Mechanistic Overview Disease-Associated Microglia Metabolic Reprogramming starts from the claim that modulating TREM2

NRF2-Mediated Metabolic Reprogramming: HBOT as Direct NAMPT/SIRT1 Activator for

Score: 0.602 · neurodegeneration · 2026-04-17

## Mechanistic Overview NRF2-Mediated Metabolic Reprogramming: HBOT as Direct NAMPT/SIRT1 Activator for Reverse Senescen

Metabolic Reprogramming via Coordinated Multi-Gene CRISPR Circuits

Score: 0.599 · neurodegeneration · 2026-04-02

## Mechanistic Overview Metabolic Reprogramming via Coordinated Multi-Gene CRISPR Circuits starts from the claim that mo

APOE4 drives astrocyte metabolic reprogramming toward glycolysis via PGC-1α supp

Score: 0.580 · neuroscience · 2026-04-22

**Molecular Mechanism and Rationale** The APOE4-driven metabolic reprogramming of astrocytes represents a complex casca

Digital Twin-Guided Metabolic Reprogramming

Score: 0.550 · neurodegeneration · 2026-04-02

## Mechanistic Overview Digital Twin-Guided Metabolic Reprogramming starts from the claim that modulating PPARGC1A/PRKAA

TREM2-Mediated Microglial Metabolic Reprogramming Accelerates Tau Pathological S

Score: 0.494 · neuroscience · 2026-04-21

## Mechanistic Overview TREM2-Mediated Microglial Metabolic Reprogramming Accelerates Tau Pathological Spread starts fro

Oligodendrocyte Progenitor Cell Metabolic Reprogramming

Score: 0.486 · neurodegeneration · 2026-04-04

## Molecular Mechanism and Rationale Oligodendrocyte progenitor cells (OPCs) undergo a critical metabolic transformatio

Metabolic Reprogramming Toward GAPDH Inhibition

Score: 0.450 · neurodegeneration · 2026-04-21

## Mechanistic Overview Metabolic Reprogramming Toward GAPDH Inhibition starts from the claim that modulating GAPDH, HK2

Mitochondrial Pyruvate Carrier Inhibition to Force Metabolic Reprogramming Towar

Score: 0.347 · metabolomics · 2026-04-25

Mitochondrial Pyruvate Carrier Inhibition to Force Metabolic Reprogramming Toward Ketone Utilization

NAD+-SIRT1-H3K9me3 restoration enables true senescence reversal, while incomplet

Score: 0.000 · Alzheimer's disease · 2026-04-26

Partial metabolic interventions (e.g., mTOR inhibition alone) suppress SASP secretion but leave growth arrest intact bec

CCR2-Mediated Microglial Replacement Drives mTOR-HIF1α Metabolic Reprogramming i

Score: 0.000 · developmental neurobiology · 2026-04-26

This hypothesis proposes that perinatal immune activation triggers a two-phase pathogenic cascade where CCR2-mediated re

TBK1 Deficiency Disrupts Microglial Metabolic Reprogramming, Promoting Glycolyti

Score: 0.000 · ALS · 2026-04-26

TBK1 loss-of-function mutations in ALS disrupt microglial metabolic homeostasis by impairing mTOR-dependent metabolic ch